Published in Arch Gen Psychiatry on June 01, 2005
Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict (2005) 3.89
Does tobacco use cause psychosis? Systematic review and meta-analysis. Lancet Psychiatry (2015) 3.56
Initial phase 2 trial of a nicotinic agonist in schizophrenia. Am J Psychiatry (2008) 3.13
It is not "either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood. Prog Neurobiol (2007) 2.85
Reduced nicotine product standards for combustible tobacco: building an empirical basis for effective regulation. Prev Med (2014) 1.88
Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacol Ther (2009) 1.67
A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia. Biol Psychiatry (2007) 1.48
ADHD and smoking: from genes to brain to behavior. Ann N Y Acad Sci (2008) 1.46
Molecular targets for treating cognitive dysfunction in schizophrenia. Schizophr Bull (2007) 1.45
Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study. Psychopharmacology (Berl) (2007) 1.44
Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia. Neuropsychopharmacology (2011) 1.42
Elevations of endogenous kynurenic acid produce spatial working memory deficits. Schizophr Bull (2006) 1.38
Are executive function and impulsivity antipodes? A conceptual reconstruction with special reference to addiction. Psychopharmacology (Berl) (2012) 1.37
Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder. Arch Gen Psychiatry (2011) 1.33
Nicotine psychobiology: how chronic-dose prospective studies can illuminate some of the theoretical issues from acute-dose research. Psychopharmacology (Berl) (2006) 1.30
Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function. Biochem Pharmacol (2007) 1.25
Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia. Schizophr Bull (2007) 1.21
Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: a randomized double-blind placebo-controlled trial. Neuropsychopharmacology (2011) 1.20
Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia? J Psychiatry Neurosci (2007) 1.18
Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men. Biochem Pharmacol (2007) 1.17
Effects of smoking abstinence, smoking cues and nicotine replacement in smokers with schizophrenia and controls. Nicotine Tob Res (2008) 1.15
A double-blind placebo-controlled experimental study of nicotine: II--Effects on response inhibition and executive functioning. Psychopharmacology (Berl) (2007) 1.14
Dimensions of impulsive behavior in adolescent smokers and nonsmokers. Exp Clin Psychopharmacol (2009) 1.11
A behavioural and functional neuroimaging investigation into the effects of nicotine on sensorimotor gating in healthy subjects and persons with schizophrenia. Psychopharmacology (Berl) (2006) 1.10
A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia. Ann Gen Psychiatry (2010) 1.10
Associations of cigarette smoking with viral immune and cognitive function in human immunodeficiency virus-seropositive women. J Neurovirol (2007) 1.07
Nicotine deprivation and trait impulsivity affect smokers' performance on cognitive tasks of inhibition and attention. Exp Clin Psychopharmacol (2009) 1.07
Effects of cigarette smoking and abstinence on Stroop task performance. Psychopharmacology (Berl) (2007) 1.06
Cognitive performance and smoking in first-episode psychosis: the self-medication hypothesis. Eur Arch Psychiatry Clin Neurosci (2010) 1.05
Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia. Schizophr Res (2007) 1.04
Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia. Psychopharmacology (Berl) (2008) 1.04
Smoking, Genetics and Schizophrenia: Evidence for Self Medication. J Dual Diagn (2007) 1.04
A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia. Biol Psychiatry (2013) 1.03
Impact of tobacco regulation on animal research: new perspectives and opportunities. Nicotine Tob Res (2012) 1.01
Alpha7 nicotinic acetylcholine receptors modulate motivation to self-administer nicotine: implications for smoking and schizophrenia. Neuropsychopharmacology (2011) 1.01
Schizophrenia, psychiatric genetics, and Darwinian psychiatry: an evolutionary framework. Schizophr Bull (2007) 1.01
Nicotine withdrawal-induced deficits in trace fear conditioning in C57BL/6 mice--a role for high-affinity beta2 subunit-containing nicotinic acetylcholine receptors. Eur J Neurosci (2009) 1.00
The Impact of Job Stress on Smoking and Quitting: Evidence from the HRS. B E J Econom Anal Policy (2010) 0.99
Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment. Neuropharmacology (2013) 0.98
Adjunctive memantine therapy for cognitive impairment in chronic schizophrenia: a placebo-controlled pilot study. Psychiatry Investig (2012) 0.98
Predictors of early abstinence in smokers with schizophrenia. J Clin Psychiatry (2008) 0.97
Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits. Neuropharmacology (2011) 0.97
Nicotinic mechanisms in the treatment of psychotic disorders: a focus on the α7 nicotinic receptor. Handb Exp Pharmacol (2012) 0.96
Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia. Drug Alcohol Depend (2009) 0.94
Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers. Neuropsychopharmacology (2010) 0.94
Risk/reward decision-making in schizophrenia: a preliminary examination of the influence of tobacco smoking and relationship to Wisconsin Card Sorting Task performance. Schizophr Res (2009) 0.93
Effects of smoking abstinence on cigarette craving, nicotine withdrawal, and nicotine reinforcement in smokers with and without schizophrenia. Nicotine Tob Res (2013) 0.92
Nicotinergic impact on focal and non-focal neuroplasticity induced by non-invasive brain stimulation in non-smoking humans. Neuropsychopharmacology (2010) 0.92
Chronic nicotine improves cognitive performance in a test of attention but does not attenuate cognitive disruption induced by repeated phencyclidine administration. Psychopharmacology (Berl) (2008) 0.91
Elevation of dopamine induced by cigarette smoking: novel insights from a [11C]-+-PHNO PET study in humans. Neuropsychopharmacology (2013) 0.91
The case in favor of E-cigarettes for tobacco harm reduction. Int J Environ Res Public Health (2014) 0.89
Multiple genes in the 15q13-q14 chromosomal region are associated with schizophrenia. Psychiatr Genet (2012) 0.89
Early nicotine withdrawal and transdermal nicotine effects on neurocognitive performance in schizophrenia. Schizophr Res (2007) 0.89
Nicotine enhances but does not normalize visual sustained attention and the associated brain network in schizophrenia. Schizophr Bull (2009) 0.89
A Review of Smoking Cessation in Bipolar Disorder: Implications for Future Research. J Dual Diagn (2012) 0.88
Cognitive performance and cigarette smoking in first-episode psychosis. Eur Arch Psychiatry Clin Neurosci (2008) 0.88
Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behavior, topography, and nicotine levels in smokers with and without schizophrenia: a preliminary study. Schizophr Res (2009) 0.88
Correlation of prepulse inhibition and Wisconsin Card Sorting Test in schizophrenia and controls: effects of smoking status. Schizophr Res (2009) 0.88
General and domain-specific neurocognitive impairments in deficit and non-deficit schizophrenia. Eur Arch Psychiatry Clin Neurosci (2011) 0.87
Effects of nicotine on social cognition, social competence and self-reported stress in schizophrenia patients and healthy controls. Eur Arch Psychiatry Clin Neurosci (2012) 0.87
Recent advances in treating cognitive impairment in schizophrenia. Psychopharmacology (Berl) (2008) 0.87
Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia. Curr Pharm Des (2014) 0.86
Cognitive effects of nicotine: genetic moderators. Addict Biol (2010) 0.85
nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives. Schizophr Res (2016) 0.84
Verbal working memory in schizophrenia from the Consortium on the Genetics of Schizophrenia (COGS) study: the moderating role of smoking status and antipsychotic medications. Schizophr Res (2014) 0.83
Cigarette Cravings, Impulsivity, and the Brain. Front Psychiatry (2015) 0.83
Neurocognitive endophenotypes in schizophrenia: modulation by nicotinic receptor systems. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.83
In vivo evidence for β2 nicotinic acetylcholine receptor subunit upregulation in smokers as compared with nonsmokers with schizophrenia. Biol Psychiatry (2013) 0.83
Cognitive effects of very low nicotine content cigarettes, with and without nicotine replacement, in smokers with schizophrenia and controls. Nicotine Tob Res (2014) 0.83
Nicotine dependence and serum BDNF levels in male patients with schizophrenia. Psychopharmacology (Berl) (2010) 0.82
Potential therapeutic uses of mecamylamine and its stereoisomers. Pharmacol Biochem Behav (2013) 0.82
Cigarette smoking and cognitive function in Chinese male schizophrenia: a case-control study. PLoS One (2012) 0.81
Cortical excitability in smoking and not smoking individuals with and without nicotine. Psychopharmacology (Berl) (2013) 0.81
Diabetes is associated with lower global cognitive function in schizophrenia. Schizophr Res (2012) 0.81
Acute nicotine administration effects on fractional anisotropy of cerebral white matter and associated attention performance. Front Pharmacol (2013) 0.81
Symptom dimensions of attention deficit hyperactivity disorder and nicotine withdrawal symptoms. J Addict Dis (2012) 0.80
Nicotine consumption and schizotypy in first-degree relatives of individuals with schizophrenia and non-psychiatric controls. Schizophr Res (2007) 0.80
Relationships between serum leptin level and severity of positive symptoms in schizophrenia. Neurosci Res (2013) 0.80
Acute effects of mecamylamine and varenicline on cognitive performance in non-smokers with and without schizophrenia. Psychopharmacology (Berl) (2013) 0.80
Socio-demographic and clinical characteristics of heavy and non-heavy smokers among schizophrenia inpatients in a Chinese Han population. Psychopharmacology (Berl) (2013) 0.80
Deconstructing anti-harm-reduction metaphors; mortality risk from falls and other traumatic injuries compared to smokeless tobacco use. Harm Reduct J (2006) 0.80
ACSL6 is associated with the number of cigarettes smoked and its expression is altered by chronic nicotine exposure. PLoS One (2011) 0.80
Predictors of smoking severity in patients with schizophrenia and alcohol use disorders. Am J Addict (2011) 0.79
Introducing oral tobacco for tobacco harm reduction: what are the main obstacles? Harm Reduct J (2007) 0.79
Smoking improves divided attention in schizophrenia. Psychopharmacology (Berl) (2014) 0.79
Cognitive Dysfunction, Affective States, and Vulnerability to Nicotine Addiction: A Multifactorial Perspective. Front Psychiatry (2016) 0.78
The nicotinergic receptor as a target for cognitive enhancement in schizophrenia: barking up the wrong tree? Psychopharmacology (Berl) (2014) 0.78
Comparison of the effectiveness of Conners' CPT and the CPT-identical pairs at distinguishing between smokers and nonsmokers with schizophrenia. Schizophr Res (2013) 0.78
Cancer 'survivor-care': I. the α7 nAChR as potential target for chemotherapy-related cognitive impairment. J Clin Pharm Ther (2010) 0.78
Negative affective states and cognitive impairments in nicotine dependence. Neurosci Biobehav Rev (2015) 0.78
Proactive outreach for smokers using VHA mental health clinics: protocol for a patient-randomized clinical trial. BMC Public Health (2014) 0.78
Pattern of smoking and nicotine dependence in patients with psychiatric disorders. Tanaffos (2012) 0.77
Mouse models for studying genetic influences on factors determining smoking cessation success in humans. Ann N Y Acad Sci (2012) 0.77
Smoking restores impaired LTD-like plasticity in schizophrenia: a transcranial direct current stimulation study. Neuropsychopharmacology (2014) 0.77
Tobacco smoking in treatment-resistant schizophrenia patients is associated with impaired cognitive functioning, more severe negative symptoms, and poorer social adjustment. Neuropsychiatr Dis Treat (2013) 0.77
The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis. BMC Psychiatry (2016) 0.77
Small effects of smoking on visual spatiotemporal processing. Sci Rep (2014) 0.76
Effect of COMT Val(158)Met genotype on nicotine withdrawal-related cognitive dysfunction in smokers with and without schizophrenia. Schizophr Res (2013) 0.76
Cognitive performance and cholinergic transmission: influence of muscarinic and nicotinic receptor blockade. Eur Arch Psychiatry Clin Neurosci (2010) 0.76
Kefir protective effects against nicotine cessation-induced anxiety and cognition impairments in rats. Adv Biomed Res (2014) 0.76
Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence. Nicotine Tob Res (2007) 5.54
Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tob Res (2008) 4.17
Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict (2005) 3.89
Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis. Psychopharmacology (Berl) (2002) 3.74
Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry (2014) 2.88
Perceived risks and benefits of smoking cessation: gender-specific predictors of motivation and treatment outcome. Addict Behav (2005) 2.45
Cue-induced brain activity changes and relapse in cocaine-dependent patients. Neuropsychopharmacology (2006) 2.32
Amygdala hyperreactivity in borderline personality disorder: implications for emotional dysregulation. Biol Psychiatry (2003) 2.31
Varenicline reduces alcohol self-administration in heavy-drinking smokers. Biol Psychiatry (2009) 2.25
Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacology (2002) 2.08
Trends in use of electronic nicotine delivery systems by adolescents. Addict Behav (2013) 2.07
Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokers. J Neurosci (2006) 1.99
The neurobiology of opioid dependence: implications for treatment. Sci Pract Perspect (2002) 1.99
Modeling the effect of alcohol on smoking lapse behavior. Psychopharmacology (Berl) (2006) 1.95
Treatment of tobacco dependence in mental health and addictive disorders. Can J Psychiatry (2009) 1.91
Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study. Biol Psychiatry (2004) 1.90
A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biol Psychiatry (2002) 1.86
Neural activity associated with stress-induced cocaine craving: a functional magnetic resonance imaging study. Psychopharmacology (Berl) (2005) 1.84
A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation. Arch Intern Med (2006) 1.78
Comparing gain- and loss-framed messages for smoking cessation with sustained-release bupropion: a randomized controlled trial. Psychol Addict Behav (2007) 1.77
Suppression of the HPA axis stress-response: implications for relapse. Alcohol Clin Exp Res (2005) 1.67
Gambling urges in pathological gambling: a functional magnetic resonance imaging study. Arch Gen Psychiatry (2003) 1.63
Mechanisms underlying the comorbidity of tobacco use in mental health and addictive disorders. Can J Psychiatry (2009) 1.61
Effects of topiramate on smoking in patients with schizoaffective disorder, bipolar type. J Clin Psychopharmacol (2008) 1.58
Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. J Psychopharmacol (2004) 1.58
Video-gaming among high school students: health correlates, gender differences, and problematic gaming. Pediatrics (2010) 1.56
beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking. Arch Gen Psychiatry (2009) 1.53
A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry (2012) 1.52
Computer-assisted cognitive remediation in schizophrenia: what is the active ingredient? Schizophr Res (2006) 1.51
A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia. Biol Psychiatry (2007) 1.48
Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study. J Neurosci (2012) 1.48
Risk factors for treatment failure in smokers: relationship to alcohol use and to lifetime history of an alcohol use disorder. Nicotine Tob Res (2008) 1.46
Neurocognitive enhancement therapy with vocational services: work outcomes at two-year follow-up. Schizophr Res (2008) 1.45
Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial. JAMA (2011) 1.44
Effects of tobacco smoking on neuropsychological function in schizophrenia in comparison to other psychiatric disorders and non-psychiatric controls. Am J Addict (2013) 1.44
Stealing among high school students: prevalence and clinical correlates. J Am Acad Psychiatry Law (2011) 1.43
Gender differences in adolescent marijuana use and associated psychosocial characteristics. J Addict Med (2011) 1.42
Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: a preliminary study. J Clin Psychopharmacol (2008) 1.41
Neurocognitive enhancement therapy with work therapy: Productivity outcomes at 6- and 12-month follow-ups. J Rehabil Res Dev (2006) 1.39
Primary defects in beta-cell function further exacerbated by worsening of insulin resistance mark the development of impaired glucose tolerance in obese adolescents. Diabetes Care (2008) 1.35
Reproducibility of the nicotine metabolite ratio in cigarette smokers. Cancer Epidemiol Biomarkers Prev (2012) 1.34
Survey of clinician attitudes toward smoking cessation for psychiatric and substance abusing clients. J Addict Dis (2008) 1.33
Neural circuits underlying emotional distress in humans. Ann N Y Acad Sci (2004) 1.29
Impulsive sensation seeking, parental history of alcohol problems, and current alcohol and tobacco use in adolescents. J Addict Med (2008) 1.28
Knowledge and perceived risk of smoking-related conditions: a survey of cigarette smokers. Prev Med (2005) 1.28
Correlates of at-risk/problem internet gambling in adolescents. J Am Acad Child Adolesc Psychiatry (2010) 1.26
A pilot study of a weight management program with food provision in schizophrenia. Schizophr Res (2007) 1.25
Effect of transdermal nicotine replacement on alcohol responses and alcohol self-administration. Psychopharmacology (Berl) (2007) 1.24
Treatment of tobacco dependence: integrating recent progress into practice. CMAJ (2007) 1.24
A cultural neuroscience approach to the biosocial nature of the human brain. Annu Rev Psychol (2012) 1.22
Combining cognitive behavioral therapy with contingency management for smoking cessation in adolescent smokers: a preliminary comparison of two different CBT formats. Am J Addict (2007) 1.20
Problematic Internet use and health in adolescents: data from a high school survey in Connecticut. J Clin Psychiatry (2011) 1.20
Comparison of expired carbon monoxide and plasma cotinine as markers of cigarette abstinence. Drug Alcohol Depend (2008) 1.19
Sources of prescriptions for misuse by adolescents: differences in sex, ethnicity, and severity of misuse in a population-based study. J Am Acad Child Adolesc Psychiatry (2009) 1.18
Confirmatory factor analysis of the Minnesota Nicotine Withdrawal Scale. Psychol Addict Behav (2007) 1.17
Sex differences in availability of β2*-nicotinic acetylcholine receptors in recently abstinent tobacco smokers. Arch Gen Psychiatry (2012) 1.17
A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms. Schizophr Res (2006) 1.16
Characterizing adolescent prescription misusers: a population-based study. J Am Acad Child Adolesc Psychiatry (2008) 1.15
Symptoms versus neurocognition as predictors of change in life skills in schizophrenia after outpatient rehabilitation. Schizophr Res (2008) 1.14
Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry (2007) 1.14
Smoking expectancies, weight concerns, and dietary behaviors in adolescence. Pediatrics (2010) 1.12
Contingency management for smoking cessation: enhancing feasibility through use of immunoassay test strips measuring cotinine. Nicotine Tob Res (2008) 1.12
A preliminary study of sustained-release bupropion for smoking cessation in bipolar disorder. J Clin Psychopharmacol (2008) 1.11
Tobacco use across the formative years: a road map to developmental vulnerabilities. Nicotine Tob Res (2003) 1.11
Health/functioning characteristics, gambling behaviors, and gambling-related motivations in adolescents stratified by gambling problem severity: findings from a high school survey. Am J Addict (2011) 1.09
Daily patterns of alcohol, cigarette, and marijuana use in adolescent smokers and nonsmokers. Addict Behav (2005) 1.09
Reliability of the Fagerström Test for Nicotine Dependence, Minnesota Nicotine Withdrawal Scale, and Tiffany Questionnaire for Smoking Urges in smokers with and without schizophrenia. Drug Alcohol Depend (2006) 1.08
Characteristics of tobacco-smoking problem gamblers calling a gambling helpline. Am J Addict (2005) 1.08
Predictors of change in life skills in schizophrenia after cognitive remediation. Schizophr Res (2008) 1.08
The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis. Schizophr Res (2011) 1.08
Characteristics of adolescent past-year gamblers and non-gamblers in relation to alcohol drinking. Addict Behav (2006) 1.07
Neuropsychological deficits are associated with smoking cessation treatment failure in patients with schizophrenia. Schizophr Res (2004) 1.07
Durability of cognitive remediation training in schizophrenia: performance on two memory tasks at 6-month and 12-month follow-up. Psychiatry Res (2004) 1.06
The relationship between age of gambling onset and adolescent problematic gambling severity. J Psychiatr Res (2012) 1.06
Subjective reactivity to the first cigarette of the day as a predictor of smoking relapse: a preliminary study. Drug Alcohol Depend (2007) 1.05
Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia. Schizophr Res (2007) 1.04
A tobacco reconceptualization in psychiatry: toward the development of tobacco-free psychiatric facilities. Am J Addict (2010) 1.04
Smoking as a complex but critical covariate in neurobiological studies of posttraumatic stress disorders: a review. J Psychopharmacol (2006) 1.03
Smoking cue reactivity in schizophrenia: effects of a nicotinic receptor antagonist. Biol Psychiatry (2005) 1.03